ask="N/A"
ask_size="N/A"
average_daily_volume="23992"
bid="N/A"
bid_size="N/A"
book_value="0.45"
change="+0.00"
change_from_200_day_moving_average="0.41"
change_from_50_day_moving_average="0.42"
change_from_52_week_high="-1.19"
change_From_52_week_low="2.33"
change_in_percent="+0.00%"
close="4.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-14.69M"
eps_estimate_current_year="-1.69"
eps_estimate_next_quarter="-0.02"
eps_estimate_next_year="-0.25"
ex_dividend_date="N/A"
float_shares="4889000"
high="4.10"
high_52_weeks="5.29"
last_trade_date="2/17/2017"
last_trade_price="4.10"
last_trade_size="143"
last_trade_time="4:02pm"
low="4.05"
low_52_weeks="1.77"
market_capitalization="62.05M"
moving_average_200_day="3.69"
moving_average_50_day="3.68"
name="NovaBay Pharmaceuticals
Inc. C"
notes="N/A"
one_year_target_price="6.75"
open="4.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+11.23%"
percent_change_from_50_day_moving_average="+11.36%"
percent_change_from_52_week_high="-22.50%"
percent_change_from_52_week_low="+131.64%"
previous_close="4.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.07"
price_per_sales="6.56"
revenue="9.45M"
shares_outstanding="15134000"
short_ratio="6.33"
stock_exchange="ASE"
symbol="NBY"
volume="5309"
weeks_range_52="1.77 - 5.29"
